Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
PUT
Ambarella
AMBA
$3.81B
| $3.73M | ﹤0.01% |
68,200
-25,900
| -28% | -$1.4M |
|
1527
CALL
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
| $3.73M | ﹤0.01% |
73,700
-81,000
| -52% | -$4.13M |
|
1528
Zebra Technologies
ZBRA
$17.8B
| $3.73M | ﹤0.01% |
40,837
+981
| +2% | +$85K |
|
|
SAFM
1529
DELISTED
Sanderson Farms Inc
SAFM
| $3.73M | ﹤0.01% |
35,857
+19,944
| +125% | +$1.88M |
|
|
TARO
1530
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $3.72M | ﹤0.01% |
31,882
+2,261
| +8% | +$250K |
|
1531
PUT
ProShares UltraPro QQQ
TQQQ
$37.9B
| $3.71M | ﹤0.01% |
1,010,400
-1,380,000
| -58% | -$4.56M |
|
1532
CALL
Ventas
VTR
$47.9B
| $3.71M | ﹤0.01% |
57,100
+37,200
| +187% | +$2.32M |
|
1533
White Mountains Insurance
WTM
$5.32B
| $3.71M | ﹤0.01% |
4,222
+41
| +1% | +$36.7K |
|
|
1534
CALL
TotalEnergies
TTE
$190B
| $3.7M | ﹤0.01% |
6,801,413
-757,463,270
| -99% | -$89.3M |
|
1535
PUT
Capri Holdings
CPRI
$1.74B
| $3.7M | ﹤0.01% |
97,100
+24,600
| +34% | +$968K |
|
1536
NNN REIT
NNN
$8.99B
| $3.7M | ﹤0.01% |
84,780
+920
| +1% | +$40.7K |
|
1537
CALL
Howmet Aerospace
HWM
$113B
| $3.69M | ﹤0.01% |
182,680
+42,135
| +30% | +$828K |
|
|
EGRX
1538
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.69M | ﹤0.01% |
44,493
+10,654
| +31% | +$792K |
|
|
MNDT
1539
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $3.68M | ﹤0.01% |
291,900
+164,800
| +130% | +$1.97M |
|
1540
Restaurant Brands International
QSR
$25.8B
| $3.68M | ﹤0.01% |
65,986
+34,479
| +109% | +$1.8M |
|
1541
AngloGold Ashanti
AU
$48.7B
| $3.68M | ﹤0.01% |
341,504
+97,127
| +40% | +$1.13M |
|
1542
PUT
Under Armour
UAA
$2.6B
| $3.68M | ﹤0.01% |
185,900
-400
| -0.2% | -$9.32K |
|
|
POT
1543
PUT
DELISTED
Potash Corp Of Saskatchewan
POT
| $3.68M | ﹤0.01% |
215,200
-191,000
| -47% | -$3.46M |
|
1544
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$312M
| $3.67M | ﹤0.01% |
93,800
-43,700
| -32% | -$1.74M |
|
1545
CALL
Range Resources
RRC
$8.95B
| $3.67M | ﹤0.01% |
126,000
-1,900
| -1% | -$58.7K |
|
|
BPT
1546
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $3.67M | ﹤0.01% |
182,321
+178,172
| +4,294% | +$4.44M |
|
|
CIM
1547
Chimera Investment
CIM
$1B
| $3.66M | ﹤0.01% |
60,482
-4,470
| -7% | -$249K |
|
1548
lululemon athletica
LULU
$14.6B
| $3.66M | ﹤0.01% |
70,545
+3,209
| +5% | +$211K |
|
1549
Keysight
KEYS
$58.3B
| $3.65M | ﹤0.01% |
101,115
+94,729
| +1,483% | +$3.53M |
|
|
MJN
1550
PUT
DELISTED
Mead Johnson Nutrition Company
MJN
| $3.65M | ﹤0.01% |
41,000
+18,700
| +84% | +$1.54M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.